In the course of tumor progression, inflammatory cytokines, including IL-6 and IL-17, facilitate the proliferation of tumor cells, and several cytokines can play an antagonizing role in the immune cells of anti-tumor responses. The gene discussed is IL17A; the disease is neoplasm.